{"id":"https://openalex.org/W12341891","doi":null,"title":"Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.","display_name":"Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.","publication_year":1989,"publication_date":"1989-11-01","ids":{"openalex":"https://openalex.org/W12341891","mag":"12341891","pmid":"https://pubmed.ncbi.nlm.nih.gov/2809398"},"language":"en","primary_location":{"id":"pmid:2809398","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2809398","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of laboratory and clinical medicine","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001465734","display_name":"A S Pappu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A S Pappu","raw_affiliation_strings":["Department of Medicine, Oregon Health Sciences University, Portland 97201"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Oregon Health Sciences University, Portland 97201","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031704422","display_name":"Illingworth Dr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D R Illingworth","raw_affiliation_strings":["Oregon Health and Science University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I165690674"],"apc_list":null,"apc_paid":null,"fwci":3.0722,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.90460805,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"114","issue":"5","first_page":"554","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.07660000026226044,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cholestyramine","display_name":"cholestyramine","score":1.0},{"id":"https://openalex.org/keywords/heterozygous-familial-hypercholesterolemia","display_name":"heterozygous familial hypercholesterolemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/mevalonate","display_name":"mevalonate","score":0.906000018119812},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cholesterol-synthesis","display_name":"cholesterol biosynthesis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9049999713897705},{"id":"https://openalex.org/keywords/bile-acid-sequestrants","display_name":"bile acid sequestrants","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-combination-therapy","display_name":"drug combination therapy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C2778697171","wikidata":"https://www.wikidata.org/wiki/Q418006","display_name":"Cholestyramine","level":3,"score":0.9523522853851318},{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.9314004778862},{"id":"https://openalex.org/C2780361610","wikidata":"https://www.wikidata.org/wiki/Q241678","display_name":"Mevalonic acid","level":4,"score":0.7877617478370667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7660112380981445},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7588263154029846},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.6976783275604248},{"id":"https://openalex.org/C10146269","wikidata":"https://www.wikidata.org/wiki/Q185557","display_name":"Excretion","level":2,"score":0.6945732235908508},{"id":"https://openalex.org/C2779120738","wikidata":"https://www.wikidata.org/wiki/Q2711291","display_name":"Familial hypercholesterolemia","level":3,"score":0.5832559466362},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.5269121527671814},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5183954834938049},{"id":"https://openalex.org/C2777320049","wikidata":"https://www.wikidata.org/wiki/Q2989497","display_name":"Hydroxymethylglutaryl-CoA reductase","level":5,"score":0.5092817544937134},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.431255042552948},{"id":"https://openalex.org/C104950815","wikidata":"https://www.wikidata.org/wiki/Q415607","display_name":"HMG-CoA reductase","level":4,"score":0.41712841391563416},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.3556312918663025},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.255179226398468},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18967890739440918},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08940494060516357}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002792","descriptor_name":"Cholestyramine Resin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002792","descriptor_name":"Cholestyramine Resin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006579","descriptor_name":"Heterozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008798","descriptor_name":"Mevalonic Acid","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:2809398","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2809398","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of laboratory and clinical medicine","raw_type":"Journal Article"},{"id":"mag:12341891","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/2809398","pdf_url":null,"source":{"id":"https://openalex.org/S26537864","display_name":"Journal of Laboratory and Clinical Medicine","issn_l":"0022-2143","issn":["0022-2143","1532-6543"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Laboratory and Clinical Medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2055281491","https://openalex.org/W2088205396","https://openalex.org/W1967383609","https://openalex.org/W1972415613","https://openalex.org/W2152103617","https://openalex.org/W2111344667","https://openalex.org/W1989046290","https://openalex.org/W2013525454","https://openalex.org/W2043775185","https://openalex.org/W2000534441"],"abstract_inverted_index":{"To":[0],"further":[1],"validate":[2],"the":[3,24,54,82,99,141,216],"usefulness":[4],"of":[5,8,16,18,28,94,102,143,154,156,164,206,214,219],"quantitative":[6],"measurements":[7],"urinary":[9,26,61,100,134,157,207],"mevalonic":[10,29,158],"acid":[11,30,56,159],"excretion":[12,27,63,101,136,155,209],"as":[13,128],"an":[14,125],"indicator":[15],"rates":[17,153,163],"cholesterol":[19,45,70,97,121,167,196,201,226],"biosynthesis,":[20],"we":[21],"have":[22,41],"determined":[23],"24-hour":[25],"in":[31,115,169,180,187,228],"patients":[32,48,76,170],"with":[33,38,49,53,77,81,117,132,171,176],"heterozygous":[34],"familial":[35,50,78],"hypercholesterolemia":[36,51,79],"treated":[37,52,80],"drugs":[39,190],"that":[40,152],"opposing":[42],"effects":[43,194,218],"on":[44,174,195,225],"biosynthesis.":[46],"In":[47,75],"bile":[55],"sequestrant":[57],"cholestyramine":[58,112,183],"(16":[59],"gms/day),":[60],"mevalonate":[62,103,135,208],"increased":[64],"by":[65,73,124,138],"28%,":[66],"whereas":[67],"low-density":[68,95,119,199],"lipoprotein":[69,96,120,200],"concentrations":[71,93,202],"decreased":[72,105,123],"21%.":[74],"3-hydroxy":[83],"3-methyl":[84],"glutaryl":[85],"coenzyme":[86],"A":[87],"reductase":[88],"inhibitor":[89],"lovastatin":[90,177],"(80":[91],"mg/day),":[92],"and":[98,108,178],"both":[104],"(by":[106],"40%":[107],"34%,":[109],"respectively).":[110],"When":[111,185],"was":[113,146],"used":[114,186],"combination":[116],"lovastatin,":[118],"levels":[122],"additional":[126],"14%":[127],"compared":[129],"to":[130,182],"monotherapy":[131],"lovastatin;":[133],"rose":[137],"(25%),":[139],"but":[140,198],"magnitude":[142],"this":[144],"increase":[145,179],"not":[147],"statistically":[148],"significant.":[149],"We":[150],"conclude":[151],"(which":[160],"may":[161],"reflect":[162],"whole":[165],"body":[166],"biosynthesis)":[168],"FH":[172],"decrease":[173,203],"therapy":[175],"response":[181],"treatment.":[184],"combination,":[188],"these":[189],"counteract":[191],"each":[192],"other's":[193],"synthesis,":[197],"further.":[204],"Measurement":[205],"affords":[210],"a":[211],"practical":[212],"means":[213],"assessing":[215],"comparable":[217],"different":[220],"dietary":[221],"or":[222],"pharmaceutical":[223],"manipulations":[224],"biosynthesis":[227],"human":[229],"beings.":[230]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}